Modus Therapeutics Holding AB (publ) (STO:MODTX)

Sweden · Delayed Price · Currency is SEK

0.415

-0.027 (-6.11%)

Apr 29, 2026, 11:25 AM CET

-67.95% (1Y)

Market Cap	53.76M
Revenue (ttm)	n/a
Net Income (ttm)	-18.54M
Shares Out	121.63M
EPS (ttm)	-0.30
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	662,091
Average Volume	1,594,215
Open	0.450
Previous Close	0.442
Day's Range	0.397 - 0.450
52-Week Range	0.208 - 5.000
Beta	0.14
RSI	61.89
Earnings Date	Apr 15, 2026

About STO:MODTX

Modus Therapeutics Holding AB (publ), a biotechnology company, develops a treatment for sepsis and septic shock in Sweden. It develops Sevuparin, a lipopolysaccharide in Phase IIa trial to treat patients with sepsis, septic shock, anemia associated with chronic kidney disease, endotoxemia, severe malaria, and other diseases involving severe systemic inflammation. Modus Therapeutics Holding AB (publ) was founded in 2011 and is headquartered in Stockholm, Sweden. [Read more]

Industry Biotechnology

Sector Healthcare

Founded 2011

Employees 2

Stock Exchange Nasdaq Stockholm

Ticker Symbol MODTX

Full Company Profile